The expansion of biologics manufacturing and aseptic drug production is driving demand for pharmaceutical isolators across the United States, but the market also faces several challenges. High capital investment, complex validation processes, and stringent FDA and current Good Manufacturing Practice (cGMP) requirements can increase implementation costs for pharmaceutical manufacturers....